|
LOC728323 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.329240E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.062160E-01 |
| Normal-vs-Stage2 |
3.533400E-01 |
| Normal-vs-Stage3 |
2.024800E-01 |
| Normal-vs-Stage4 |
1.817220E-01 |
| Stage1-vs-Stage2 |
7.187200E-01 |
| Stage1-vs-Stage3 |
8.262800E-01 |
| Stage1-vs-Stage4 |
7.717800E-01 |
| Stage2-vs-Stage3 |
8.662600E-01 |
| Stage2-vs-Stage4 |
5.997200E-01 |
| Stage3-vs-Stage4 |
6.351600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.060370E-01 |
| Normal-vs-AfricanAmerican |
3.406000E-01 |
| Normal-vs-Asian |
9.855200E-01 |
| Caucasian-vs-AfricanAmerican |
5.340600E-01 |
| Caucasian-vs-Asian |
4.496000E-01 |
| AfricanAmerican-vs-Asian |
6.356000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.546030E-02 |
| Normal-vs-Female |
8.185800E-01 |
| Male-vs-Female |
5.661400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.744300E-02 |
| Normal-vs-Extreme_Weight |
6.479000E-03 |
| Normal-vs-Obese |
6.792200E-01 |
| Normal-vs-Extreme_Obese |
3.728800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.463400E-01 |
| Normal_Weight-vs-Obese |
1.113650E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.773200E-01 |
| Extreme_Weight-vs-Obese |
2.076100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.348800E-01 |
| Obese-vs-Extreme_Obese |
6.177200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.265800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.497200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.854400E-02 |
| Normal-vs-Age(81-100Yrs) |
9.614100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.897000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.437800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.593600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.285980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.354200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.404800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.896300E-02 |
| Normal-VS-Type2 PRCC |
3.992000E-01 |
| Normal-VS-KIRP CIMP |
8.559400E-01 |
| Normal-VS-Unclassified PRCC |
2.923600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.767450E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.532600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.218200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.951400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.175200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.791200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.294000E-02 |
| Normal-vs-N1 |
8.535200E-01 |
| Normal-vs-N2 |
7.875500E-02 |
| N0-vs-N1 |
1.812590E-01 |
| N0-vs-N2 |
4.952400E-01 |
| N1-vs-N2 |
1.524160E-01 |
|
|
